Clinical trials: Fibromuscular Dysplasia, open to volunteers
Renal Artery Fibromuscular Dysplasia
Renal Artery Fibromuscular Dysplasia Registry
1. Study name: A Prospective Study of the Renal artery fibromuscular dysplasia Registry in China 2. Rationale: Fibromuscular dysplasia (FMD) is an idiopathic systemic noninflammatory arterial disease resulting in narrowing of…
- Trial name
- NCT05363748
- Where
- China
- Volunteers
- 500 people
- Sponsor
- Shanghai Jiao Tong University School of Medicine
Adenine Phosphoribosyltransferase Deficiency, AH Amyloidosis
National Registry of Rare Kidney Diseases
The goal of this National Registry is to is to collect information from patients with rare kidney diseases, so that it that can be used for research.
- Conditions
- Adenine Phosphoribosyltransferase Deficiency, AH Amyloidosis, AHL Amyloidosis, AL Amyloidosis
- Trial name
- RaDaR (NCT06065852)
- Where
- United Kingdom
- Volunteers
- 35,000 people
- Sponsor
- UK Kidney Association
Fibromuscular Dysplasia
European/International FMD Registry and Initiative
The main objectives of FEIRI are: (i) To describe the demographic and arterial characteristics of FMD and related diseases at a global scale and according to countries and/or ethnic origin (ii) To evaluate the incidence and…
- Trial name
- FEIRI (NCT04804683)
- Testing
- Genetic dissection of Fibromuscular Dysplasia, Search for diagnostic and prognostic biomarkers of Fibromuscular Dysplasia
- Where
- Belgium
- Volunteers
- 5,000 people
- Sponsor
- Cliniques universitaires Saint-Luc- Université Catholique de Louvain